XLCARE PHARMACEUTICALS INC
Federal contract awards won by XLCARE PHARMACEUTICALS INC (UEI MEAUS5WHBJJ7), 2021–2026 — public record from USAspending.
Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
14
awards
$314,140,272
total value
1
agency
Agencies buying from XLCARE PHARMACEUTICALS INC
What XLCARE PHARMACEUTICALS INC sells
Awards
NEW AWARD FOR CARBIDOPA/LEVODOPA IMMEDIATE-RELEASE (IR) TABLETS WITH XLCARE PHARMACEUTICALS, INC. ORDERING PERIOD IS JUNE 21, 2026 TO JUNE 20, 2027 WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs · $11,802,605 · Jun 21, 2026
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs · $50,000,000 · Jun 1, 2026
NEW AWARD FOR ALLOPURINOL TABLETS WITH XLCARE PHARMACEUTICALS, INC. ORDERING PERIOD IS MAY 30, 2026 TO MAY 29, 2027 WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs · $17,786,862 · May 30, 2026
NEW AWARD FOR LEVETIRACETAM TABLETS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD FEB 5, 2026 TO MAY 23, 2026, WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs · $9,568,741 · May 24, 2026
3 LINE ITEMS FOR MONTELUKAST 10MG TABLET. AWARDED FOR A BASE YEAR OF 5/10/2026 TO 5/9/2027 PLUS 4 ONE-YEAR OPTION PERIODS.
Department of Veterans Affairs · $24,826,671 · May 10, 2026
NEW AWARD FOR TOPIRAMATE TABLETS WITH XLCARE. ORDERING PERIOD IS OCT 31, 2025 TO OCT 30, 2026 WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs · $14,134,788 · Oct 31, 2025
NEW AWARD FOR LOSARTAN TABLETS WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 9/24/2025-9/23/2026.
Department of Veterans Affairs · $37,933,103 · Sep 24, 2025
NEW AWARD FOR LEVOTHYROXINE NA TABLETS WITH XLCARE PHARMACEUTICALS, INC. BASE YEAR ORDERING PERIOD IS JAN 27, 2025 THROUGH JAN 26, 2026 WITH FOUR ONE-YEAR OPTIONS
Department of Veterans Affairs · $40,144,392 · Jan 27, 2025
NEW AWARD FOR OXCARBAZEPINE WITH XLCARE PHARMACEUTICALS. PERIOD OF PERFORMANCE IS OCT 14, 2024 TO OCT 13, 2025 WITH FOUR ONE-YEAR OPTIONS
Department of Veterans Affairs · $11,065,099 · Oct 14, 2024
AWARD TO XLCARE PHARMACEUTICALS FOR METHOCARBAMOL TABLETS FOR THE BASE YEAR WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs · $11,608,274 · Mar 23, 2024
NEW AWARD FOR GABAPENTIN CAPSULES WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS NOVEMBER 11, 2023 THROUGH NOVEMBER 10, 2024 WITH FOUR ONE YEAR OPTIONS.
Department of Veterans Affairs · $54,110,891 · Nov 11, 2023
NEW AWARD FOR LACOSAMIDE INJECTIONS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD IS MAY 13, 2023 TO MAY 12, 2024 WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs · $761,850 · May 13, 2023
NEW AWARD FOR PANTOPRAZOLE TABLETS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD IS JUNE 26, 2022 TO JUNE 25, 2023 WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs · $28,973,376 · Jun 26, 2022
2 LINE ITEMS DUTASTERIDE CAPSULES. AWARDED FOR A BASE YEAR OF 12/23/2021 TO 12/22/2022 PLUS 4 ONE-YEAR OPTION PERIODS.
Department of Veterans Affairs · $1,423,620 · Dec 23, 2021
Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.
Search open bids